Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 16

Results For "expansion"

1195 News Found

Co-Diagnostics JV leases manufacturing facility in Saudi Arabia
Medical Device | May 11, 2026

Co-Diagnostics JV leases manufacturing facility in Saudi Arabia

CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City


Artemis Medicare Q4 FY26 revenue rises 16.4% to Rs. 27,923 lakh, net profit jumps 32.1%
Hospitals | May 09, 2026

Artemis Medicare Q4 FY26 revenue rises 16.4% to Rs. 27,923 lakh, net profit jumps 32.1%

The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies


Lonza surges on biologics boom
News | May 09, 2026

Lonza surges on biologics boom

Expands manufacturing push & locks in major growth deals


Uttar Pradesh poised to become India’s premier healthcare and medical device hub: Dr. G.N. Singh
Policy | May 08, 2026

Uttar Pradesh poised to become India’s premier healthcare and medical device hub: Dr. G.N. Singh

Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state


Vijaya Diagnostic Q4FY26 revenue jumps 27%, EBITDA margin expands to 43.5%
Healthcare | May 08, 2026

Vijaya Diagnostic Q4FY26 revenue jumps 27%, EBITDA margin expands to 43.5%

With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion


Biocon Q4 profit jumps 64%; FY26 revenue crosses Rs. 16,900 crore
Biopharma | May 08, 2026

Biocon Q4 profit jumps 64%; FY26 revenue crosses Rs. 16,900 crore

The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year


Lupin Q4 FY26 PBT jumps 115% to Rs 19,280 million
News | May 08, 2026

Lupin Q4 FY26 PBT jumps 115% to Rs 19,280 million

U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit


Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore
Healthcare | May 08, 2026

Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore

Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands


Moderna’s mRNA flu vaccine outperforms standard shot in Phase 3 trial
Clinical Trials | May 08, 2026

Moderna’s mRNA flu vaccine outperforms standard shot in Phase 3 trial

NEJM study shows strong protection across strains


Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO
Medical Device | May 08, 2026

Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO

The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform